Regulators Can’t Seem To Tamp Down Telemedicine, And That’s A Big Sign Of Change
This article was published on April 16, 2018 on Forbes, written by Leah Binder. Photo Source: Shutterstock, Forbes.com article
In most industries, if consumers like a new innovation in the market, no matter how disruptive, it can survive attacks from competitors. Traditionally in health care the opposite is true: disruption dooms an innovation to failure. Competitors will bury it under a mountain of regulatory barriers. That’s because the patient isn’t the prime consumer in health care, payors like Medicare and health plans are. They in turn focus on the views of health care providers, who keep them in business and wield […]
